COMPASS THERAPEUTICS INC (CMPX) Stock Cash Flow
NASDAQ:CMPX - Nasdaq - US20454B1044 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -47.76M | -42.49M | -39.23M | -82.18M | -29.50M | |||
| Depreciation Amortization | 608.00K | 699.00K | 780.00K | 570.00K | 2.40M | |||
| Change In Working Capital | -7.88M | -2.91M | -1.26M | 6.25M | -4.65M | |||
| Interest Paid | N/A | N/A | 0.00 | 370.00K | 850.00K | |||
| Other non cash items | 6.98M | 4.08M | 5.58M | 55.70M | 4.94M | |||
| OPERATING CASH FLOW | -48.05M | -40.62M | -34.13M | -19.67M | -26.80M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -30.00K | -210.00K | -1.89M | -110.00K | |||
| Other Investing Activity | 37.77M | 27.00M | -150.99M | 120.00K | 140.00K | |||
| INVESTING CASH FLOW | 37.72M | 26.96M | -151.20M | -1.77M | 40.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | -9.38M | -5.63M | |||
| Stock Issued/Repurchased | 18.11M | 3.19M | 76.25M | 128.27M | 60.48M | |||
| Other Financing Activity | -834.00K | -253.00K | -500.00K | -280.00K | -6.32M | |||
| FINANCING CASH FLOW | 17.28M | 2.94M | 75.76M | 118.61M | 48.54M | |||
| CHANGE IN CASH | 6.94M | -10.72M | -109.57M | 97.17M | 21.78M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -48.05M | -40.62M | -34.13M | -19.67M | -26.80M | |||
| Capital Expenditure | N/A | -30.00K | -210.00K | -1.89M | -110.00K | |||
| FREE CASH FLOW | -48.10M | -40.65M | -34.34M | -21.56M | -26.91M | |||
All data in USD